# Arcturus Therapeutics Holdings Inc.: insider transactions

ARCT · Nasdaq · CIK 1768224 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arct.md) · [Financials](/companies/arct/financials.md) · [Filings](/companies/arct/filings.md) · [Insiders](/companies/arct/insiders.md)

## All transactions: 5

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-08-11 | [Ultragenyx Pharmaceutical Inc.](/insiders/1515673.md) | Director | Sale (S) | 75,000 | $45.83 | $3.4m | [Form 4](/filings/0001209191-21-051182.md) |
| 2021-08-10 | [Ultragenyx Pharmaceutical Inc.](/insiders/1515673.md) | Director | Sale (S) | 725,000 | $55.44 | $40.2m | [Form 4](/filings/0001209191-21-051182.md) |
| 2020-12-09 | [Ultragenyx Pharmaceutical Inc.](/insiders/1515673.md) | Director, 10% owner | Sale (S) | 357,745 | $94.97 | $34.0m | [Form 4](/filings/0001209191-20-062733.md) |
| 2020-12-08 | [Ultragenyx Pharmaceutical Inc.](/insiders/1515673.md) | Director, 10% owner | Sale (S) | 442,255 | $105.54 | $46.7m | [Form 4](/filings/0001209191-20-062733.md) |
| 2020-05-20 | [Ultragenyx Pharmaceutical Inc.](/insiders/1515673.md) | Director, 10% owner | Option exercise (M) | 600,000 | $16.00 | $9.6m | [Form 4](/filings/0001209191-20-031641.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 06:06 ET. No prices; not investment advice.